Related Experiment Video
Updated: Aug 22, 2025

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
Structural Investigation of Betulinic Acid Plasma Metabolites by Tandem Mass Spectrometry
Roxana Ghiulai1,2, Marius Mioc2,3, Roxana Racoviceanu2,3
1Department of Pharmacology-Pharmacotherapy, Victor Babes University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Sq., 300041 Timisoara, Romania.
Abstract:
Betulinic acid (BA) has been extensively studied in recent years mainly for its antiproliferative and antitumor effect in various types of cancers. Limited data are available regarding the pharmacokinetic profile of BA, particularly its metabolic transformation in vivo. In this study, we present the screening and structural investigations by ESI Orbitrap MS in the negative ion mode and CID MS/MS of phase I and phase II metabolites detected in mouse plasma after the intraperitoneal administration of a nanoemulsion containing BA in SKH 1 female mice. Obtained results indicate that the main phase I metabolic reactions that BA undergoes are monohydroxylation, dihydroxylation, oxidation and hydrogenation, while phase II reactions involved sulfation, glucuronidation and methylation. The fragmentation pathway for BA and its plasma metabolites were elucidated by sequencing of the precursor ions by CID MS MS experiments.
Insights
Betulinic acid (BA) undergoes Phase I and Phase II metabolic transformations in mice, including hydroxylation, oxidation, sulfation, and glucuronidation. Understanding these metabolic pathways is crucial for its potential therapeutic applications in cancer treatment.
Area of Science:
- Pharmacology
- Metabolomics
- Cancer Research
Background:
- Betulinic acid (BA) shows significant antiproliferative and antitumor effects.
- Limited information exists on the in vivo pharmacokinetic profile and metabolic transformation of BA.
Purpose of the Study:
- To screen and structurally investigate the phase I and phase II metabolites of betulinic acid in mouse plasma.
- To elucidate the metabolic pathways and fragmentation patterns of BA and its metabolites.
Main Methods:
- Administration of a nanoemulsion containing BA to SKH 1 female mice.
- Analysis of mouse plasma using Electrospray Ionization Orbitrap Mass Spectrometry (ESI Orbitrap MS) in negative ion mode.
- Structural elucidation of metabolites via Collision-Induced Dissociation tandem Mass Spectrometry (CID MS/MS).
Main Results:
- Identified key phase I metabolic reactions: monohydroxylation, dihydroxylation, oxidation, and hydrogenation.
- Identified key phase II metabolic reactions: sulfation, glucuronidation, and methylation.
- Elucidated the fragmentation pathways for BA and its detected plasma metabolites.
Conclusions:
- Betulinic acid undergoes diverse phase I and phase II metabolic transformations in vivo.
- The identified metabolites and their fragmentation pathways provide critical insights into BA's pharmacokinetics.
- This study lays the groundwork for further research into BA's therapeutic potential and drug development.
More Related Videos
Related Concept Videos
Peptide Identification Using Tandem Mass Spectrometry
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
Mass Spectrometry: Carboxylic Acid, Ester, and Amide Fragmentation
For example,...
Mass Spectrometry: Aromatic Compound Fragmentation
Mass Spectrometry: Alcohol Fragmentation

